Morbilliform rash after administration of Pfizer-BioNTech COVID-19 mRNA vaccine

Dermatol Online J. 2021 Jan 15;27(1):13030/qt4xs486zg.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Adult
  • BNT162 Vaccine
  • COVID-19 / prevention & control*
  • COVID-19 Vaccines / adverse effects*
  • Drug Eruptions / etiology*
  • Health Personnel
  • Humans
  • Male
  • Recurrence
  • SARS-CoV-2

Substances

  • COVID-19 Vaccines
  • BNT162 Vaccine